Dr Emily Anne Sander, MD | |
202 Lawrence Ln, Yreka, CA 96097-3341 | |
(530) 572-1566 | |
Not Available |
Full Name | Dr Emily Anne Sander |
---|---|
Gender | Female |
Speciality | Integrative Medicine |
Location | 202 Lawrence Ln, Yreka, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1568705671 | NPI | - | NPPES |
1568705671 | Medicaid | NY |
Mailing Address | Practice Location Address |
---|---|
Dr Emily Anne Sander, MD 202 Lawrence Ln, Yreka, CA 96097-3341 Ph: (530) 572-1566 | Dr Emily Anne Sander, MD 202 Lawrence Ln, Yreka, CA 96097-3341 Ph: (530) 572-1566 |
News Archive
W. L. Gore & Associates (Gore) reported the complete enrollment in a post-market approval study designed to better characterize the performance of the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface in treating peripheral vascular disease (PVD) of the superficial femoral artery (SFA). The 11 participating sites enrolled a total of 120 patients in the Gore VIPER (GOREĀ® VIABAHNĀ® Endoprosthesis with Heparin Bioactive Surface for SuPERficial Femoral Artery Endoluminal Bypass) Study since initiation.
A team of 18 researchers at Moffitt Cancer Center in Tampa, Fla., have found that treating high-risk, soft tissue sarcoma patients with a combination of implanted dendritic cells (immune system cells) and fractionated external beam radiation (EBRT) provided more than 50 percent of their trial patients with tumor-specific immune responses lasting from 11 to 42 weeks.
More apparent conflict of interest violations in applications for research grants in California's $6 billion stem cell program were revealed and the Foundation for Taxpayer and Consumer Rights (FTCR) called for all the tainted applications to be rejected.
A leading cancer researcher has identified very high levels of doctor-patient trust and confidence within the NHS.
The 10-step Baby-Friendly Hospital Initiative, aimed at promoting breastfeeding initiation and exclusivity to improve early infant health in the U.S. is having a positive impact on some measures, but others have proven more challenging to influence or assess.
› Verified 7 days ago